MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MEISNER, H.
Right arrow Articles by NEET, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MEISNER, H.
Right arrow Articles by NEET, K.

Molecular Pharmacology, Vol 14, 337-346, Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics

Competitive Binding of Long-Chain Free Fatty Acids, Octanoate, and Chlorophenoxyisobutyrate to Albumin

HERMAN MEISNER 1 and KENNETH NEET 1

1 Department of Pharmacology and Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio 44106

The mechanism of binding of certain fatty acids and the drug chlorophenoxyisobutyrate (CPIB) to defatted bovine serum albumin has been studied by analysis of the mutual displacement of these ligands. The displacement of one ligand by another was measured at pH 7.45 by equilibrium partitioning between hexane and an aqueous phase, and by ultrafiltration. The ligand-inhibitor pairs were [14C]palmitate vs. CPIB, octanoate, or stearate, [14C]CPIB vs. octanoate or palmitate, and [14C]octanoate vs. CPIB. Association constants (Ka) were measured for ligands in separate experiments, and inhibition constants (Ki) for competitors were estimated from linear double-reciprocal plots of the low ligand concentration region. In all cases a competitive type of displacement of ligand from a high-affinity site(s) by the inhibitor was observed. When Ka inhibitor was equal to or greater than Ka ligand, the inhibition constant (Ki) equaled Ka inhibitor, indicative of classical competitive inhibition. An example of this type is [14C]CPIB (Ka 2 x 105 M-1) displacement by palmitate (Ki = Ka = 5 x 106 M-1). However, when Ka inhibitor was less than Ka ligand, as in the case of [14C]palmitate displacement by CPIB, the calculated Ki was less than Ka inhibitor. Furthermore, Ki. decreased as the inhibitor concentration rose. Although data can be interpreted by a model in which common primary binding sites exist on albumin for medium- or long-chain free fatty acids and CPIB, a more complex interpretation than simple competitive inhibition may be required to explain the unequal Ki and Ka values.

Note:
ACKNOWLEDGMENTS We thank Mrs. Rosario Bowen for her excellent technical assistance, and Dr. Robert Ainslie for helpful discussions during the preparation of the manuscript.

Submitted on June 20, 1977
Accepted on October 12, 1977







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics